StockData
Immix Biopharma, Inc. logo

Immix Biopharma, Inc. (IMMX) income statement

IMMXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30
$6.96−0.08 (-1.14%)

Close on Nov 20, 2026Market cap $497.91MP/E –Yield –

See a number that looks wrong?